Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study
Abstract Background Fibroblast growth factor-23 (FGF23) and α-klotho are associated with anemia in patients with chronic kidney disease. In this post hoc analysis of the ASTRIO study (UMIN000019176), we investigated the relationship between FGF23 and α-klotho during treatment with an iron-based phos...
Main Authors: | Kyoko Ito, Keitaro Yokoyama, Masaaki Nakayama, Masafumi Fukagawa, Hideki Hirakata |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-021-02575-9 |
Similar Items
-
Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide
by: Masaaki Nakayama, et al.
Published: (2018-03-01) -
Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate
by: Keitaro Yokoyama, et al.
Published: (2017-05-01) -
Segregating the effects of ferric citrate‐mediated iron utilization and FGF23 in a mouse model of CKD
by: Michael P. Liesen, et al.
Published: (2022-06-01) -
Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease
by: Ping-Hsun Wu, et al.
Published: (2020-12-01) -
THE SURFACE PHOTOCHEMISTRY OF PROCYMIDONE IN PRESENCE OF AMMONIUM FERRIC CITRATE
by: Ivan Osipov
Published: (2015-12-01)